{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:39:43Z","timestamp":1792456783294,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":92,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-63050-9","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T04:37:58Z","timestamp":1784522278000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Conditioning-adapted methotrexate in cord blood transplantation for high-risk acute myeloid leukemia: a nationwide Japanese cohort analysis"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6143-7906","authenticated-orcid":false,"given":"Satoshi","family":"Yamasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamitsu","family":"Yanada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Toubai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaito","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatsugu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Onizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norimichi","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Kawakita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Onodera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Nagafuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Nakasone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Ishimaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Konuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"issue":"5","key":"63050_CR1","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3324\/haematol.2015.132860","volume":"101","author":"R Storb","year":"2016","unstructured":"Storb, R. & Sandmaier, B. M. Nonmyeloablative allogeneic hematopoietic cell transplantation. Haematologica 101 (5), 521\u2013530 (2016).","journal-title":"Haematologica"},{"issue":"3","key":"63050_CR2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1532\/IJH97.06239","volume":"86","author":"Y Atsuta","year":"2007","unstructured":"Atsuta, Y. et al. Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System. Int. J. Hematol. 86 (3), 269\u2013274 (2007).","journal-title":"Int. J. Hematol."},{"issue":"1","key":"63050_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12185-015-1894-x","volume":"103","author":"Y Atsuta","year":"2016","unstructured":"Atsuta, Y. Introduction of transplant registry unified management program 2 (TRUMP2): Scripts for TRUMP data analyses, part I (variables other than HLA-related data). Int. J. Hematol. 103 (1), 3\u201310 (2016).","journal-title":"Int. J. Hematol."},{"issue":"2","key":"63050_CR4","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/j.1365-2141.2009.07883.x","volume":"147","author":"V Rocha","year":"2009","unstructured":"Rocha, V., Gluckman, E. & Eurocord-Netcord registry and European Blood and Marrow Transplant group. Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors. Br. J. Haematol. 147 (2), 262\u2013274 (2009).","journal-title":"Br. J. Haematol."},{"issue":"11","key":"63050_CR5","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/j.bbmt.2010.08.011","volume":"16","author":"JN Barker","year":"2010","unstructured":"Barker, J. N. et al. Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities. Biol. Blood Marrow Transplant. 16(11), 1541\u20131548 (2010).","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"7","key":"63050_CR6","first-page":"540","volume":"27","author":"DM Ponce","year":"2021","unstructured":"Ponce, D. M. et al. Guidelines for the prevention and management of graft-versus-host disease after cord blood transplantation. Transpl. Cell. Ther. 27 (7), 540\u2013544 (2021).","journal-title":"Transpl. Cell. Ther."},{"issue":"5","key":"63050_CR7","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.bbmt.2015.01.023","volume":"21","author":"N Bejanyan","year":"2015","unstructured":"Bejanyan, N. et al. Higher dose of mycophenolate mofetil reduces acute graft-versus-host disease in reduced-intensity conditioning double umbilical cord blood transplantation. Biol. Blood Marrow Transplant. 21(5), 926\u2013933 (2015).","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"7","key":"63050_CR8","volume":"2014","author":"M Kharfan-Dabaja","year":"2014","unstructured":"Kharfan-Dabaja, M. et al. Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantation. Cochrane Database Syst. Rev. 2014(7), CD010280 (2014).","journal-title":"Cochrane Database Syst. Rev."},{"issue":"9","key":"63050_CR9","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/bmt.2017.116","volume":"52","author":"S Terakura","year":"2017","unstructured":"Terakura, S. et al. GvHD prophylaxis after single-unit reduced intensity conditioning cord blood transplantation in adults with acute leukemia. Bone Marrow Transpl. 52 (9), 1261\u20131267 (2017).","journal-title":"Bone Marrow Transpl."},{"issue":"6","key":"63050_CR10","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1007\/s12185-021-03097-8","volume":"113","author":"S Terakura","year":"2021","unstructured":"Terakura, S. et al. Effect of methotrexate dose in graft-versus-host disease prophylaxis after single-unit cord blood transplantation in adult acute myeloid leukemia. Int. J. Hematol. 113 (6), 840\u2013850 (2021).","journal-title":"Int. J. Hematol."},{"key":"63050_CR11","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2025018626","author":"S Yamasaki","year":"2026","unstructured":"Yamasaki, S. et al. GVHD prophylaxis after cord blood transplantation in patients with high-risk AML: A nationwide Japanese cohort study. Blood Adv. https:\/\/doi.org\/10.1182\/bloodadvances.2025018626 (2026).","journal-title":"Blood Adv."},{"key":"63050_CR12","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2025.2604565","author":"K Harada","year":"2025","unstructured":"Harada, K. et al. Cord blood versus bone marrow\/peripheral blood stem cell transplantation under reduced-intensity conditioning in high-risk acute myeloid leukemia and myelodysplastic syndromes. Leuk Lymphoma https:\/\/doi.org\/10.1080\/10428194.2025.2604565 (2025).","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"63050_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13024","volume":"21","author":"Y Inui","year":"2019","unstructured":"Inui, Y. et al. Human herpesvirus 6 encephalitis in patients administered mycophenolate mofetil as prophylaxis for graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transpl. Infect. Dis. 21(1), e13024 (2019).","journal-title":"Transpl. Infect. Dis."},{"issue":"24","key":"63050_CR14","doi-asserted-by":"publisher","first-page":"6291","DOI":"10.1182\/bloodadvances.2022008047","volume":"6","author":"I Politikos","year":"2022","unstructured":"Politikos, I. et al. Extended-duration letermovir prophylaxis for cytomegalovirus infection after cord blood transplantation in adults. Blood Adv. 6(24), 6291\u20136300 (2022).","journal-title":"Blood Adv."},{"key":"63050_CR15","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014676","author":"SS Dadwal","year":"2023","unstructured":"Dadwal, S. S., Papanicolaou, G. A. & Boeckh, M. How I prevent viral reactivation in high-risk patients. Blood. https:\/\/doi.org\/10.1182\/blood.2021014676 (2023).","journal-title":"Blood"},{"issue":"10","key":"63050_CR16","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/s41409-024-02331-1","volume":"59","author":"G Bug","year":"2024","unstructured":"Bug, G. et al. Tacrolimus versus cyclosporine a combined with post-transplantation cyclophosphamide for AML in first complete remission: A study from the acute leukemia working party (EBMT). Bone Marrow Transplant. 59(10), 1394\u20131401 (2024).","journal-title":"Bone Marrow Transplant."},{"issue":"12","key":"63050_CR17","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner, H. et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood 140 (12), 1345\u20131377 (2022).","journal-title":"Blood"},{"issue":"20","key":"63050_CR18","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber, D. A. et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127 (20), 2391\u20132405 (2016).","journal-title":"Blood"},{"issue":"7","key":"63050_CR19","doi-asserted-by":"publisher","first-page":"e481","DOI":"10.1016\/S2352-3026(21)00134-4","volume":"8","author":"JE Lancet","year":"2021","unstructured":"Lancet, J. E. et al. CPX-351 versus 7\u2009+\u20093 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trial. Lancet Haematol. 8(7), e481\u2013e491 (2021).","journal-title":"Lancet Haematol."},{"issue":"3","key":"63050_CR20","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","volume":"15","author":"S Giralt","year":"2009","unstructured":"Giralt, S. et al. Reduced intensity conditioning regimen workshop: Defining the dose spectrum\u2013Report of a workshop convened by the Center for International Blood and Marrow Transplant Research. Biol. Blood Marrow Transpl. 15 (3), 367\u2013369 (2009).","journal-title":"Biol. Blood Marrow Transpl."},{"issue":"6","key":"63050_CR21","first-page":"825","volume":"15","author":"PD Przepiorka","year":"1995","unstructured":"Przepiorka, P. D. et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transpl. 15 (6), 825\u2013828 (1995).","journal-title":"Bone Marrow Transpl."},{"issue":"12","key":"63050_CR22","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","volume":"11","author":"AH Filipovich","year":"2005","unstructured":"Filipovich, A. H. et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol. Blood Marrow Transpl. 11 (12), 945\u2013956 (2005).","journal-title":"Biol. Blood Marrow Transpl."},{"key":"63050_CR23","unstructured":"European Society for Blood and Marrow Transplantation (EBMT). Guide to completion \u2013 Status at HCT\/CT\/IST Day 0 (version 2.0). EBMT. (2024). Available at: https:\/\/www.ebmt.org\/ (accessed March 11, 2026)."},{"issue":"8","key":"63050_CR24","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1182\/blood-2014-10-609032","volume":"125","author":"SG Holtan","year":"2015","unstructured":"Holtan, S. G. et al. Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation. Blood 125 (8), 1333\u20131338 (2015).","journal-title":"Blood"},{"issue":"4","key":"63050_CR25","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/bmt.2015.305","volume":"51","author":"A Ruggeri","year":"2016","unstructured":"Ruggeri, A., Labopin, M., Ciceri, F., Mohty, M. & Nagler, A. Definition of GvHD-free, relapse-free survival for registry-based studies: An ALWP-EBMT analysis on patients with AML in remission. Bone Marrow Transpl. 51 (4), 610\u2013611 (2016).","journal-title":"Bone Marrow Transpl."},{"key":"63050_CR26","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"J Fine","year":"1999","unstructured":"Fine, J. & Gray, R. A proportional hazards model for the subdistribution of a competing risk. J. Am. Stat. Assoc. 94, 496\u2013509 (1999).","journal-title":"J. Am. Stat. Assoc."},{"issue":"3","key":"63050_CR27","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1214\/aos\/1176350951","volume":"16","author":"RJ Gray","year":"1988","unstructured":"Gray, R. J. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann. Statist. 16 (3), 1141\u20131154 (1988).","journal-title":"Ann. Statist"},{"key":"63050_CR28","first-page":"191","volume-title":"Evaluation of Chemotherapeutic Agents","author":"DA Karnofsky","year":"1949","unstructured":"Karnofsky, D. A. & Burchenal, J. H. The clinical evaluation of chemotherapeutic agents in cancer. In Evaluation of Chemotherapeutic Agents (ed. MacLeod, C. M.) 191\u2013205 (Columbia University Press, 1949)."},{"issue":"8","key":"63050_CR29","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","volume":"106","author":"ML Sorror","year":"2005","unstructured":"Sorror, M. L. et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: A new tool for risk assessment before allogeneic HCT. Blood 106 (8), 2912\u20132919 (2005).","journal-title":"Blood"},{"issue":"3","key":"63050_CR30","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda, Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant. 48(3), 452\u2013458 (2013).","journal-title":"Bone Marrow Transplant."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63050-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63050-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63050-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:56:27Z","timestamp":1792454187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63050-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["63050"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-63050-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"16 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Data Management Committee of the Japanese Society for Hematopoietic Cell Transplantation and the Institutional Review Board of St. Mary\u2019s Hospital.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Transplant Registry Unified Management Program database contains physician-reviewed data. Observational studies based on the Transplant Registry Unified Management Program database are performed with informed consent.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"32967"}}